- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06721702
Motivational Interviewing and Addiction (MI-IA-DGA)
The Effect of Motivational Interviewing on Internet Addiction and Digital Game Addiction in Adolescents
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Sivas, Turkey
- Şehit Muhammet Onur Demir Anadolu High School, Halis Gülle Anadolu High School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being a ninth-grade student
- Being in the intention or pre-intention stage according the change assessment form
- Being addicted to digital games
- Having family approval
- Volunteering to participate in the research
Exclusion Criteria:
• Having any physical and mental illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group: Motivational Interviewing
The motivational interview, consisting of six sessions, including the preparation session, was applied to the intervention group.Each session lasted an average of 40 minutes.
Motivational interviewing sessions were conducted with nine different groups consisting of five people in the intervention group.
|
Motivational interviews were administered as the intervention of the research.
Motivational interviewing consists of two stages.
In the first stage, the four principles of motivational interviewing (developing contradiction, showing empathy, supporting self-efficacy, and resolving resistance) are aimed at providing motivation in individuals.
The second stage is strengthening the commitment to change.
|
|
No Intervention: Control Group
Control group did not receive any intervention other than the daily routine practices.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Internet Addiction
Time Frame: 6 months up to July 2024
|
Internet Addiction Test Short Form (YIBT-SF) was developed by Young (1998). It was converted into a short form by Pawlikowski et al (2013). It is a 5-point Likert-type scale consisting of 12 items and a single factor adapted into Turkish by Kutlu et al. in 2016. The scores obtained from the scale vary between 12 and 60. High scores obtained from the scale indicate a high level of dependency. The Cronbach's alpha coefficient obtained in the reliability study was found to be 0.86 in adolescents. |
6 months up to July 2024
|
|
Digital Game Addiction
Time Frame: 6 months up to July 2024
|
The Digital Game Addiction Scale (DGAS) was developed by Lemmens et al. (2009) to determine the problematic digital game playing behaviors of adolescents aged 12 - 18 years.
The scale is a seven-item short form of the DGAS - 21, consisting of 21 items and seven sub-dimensions.
The validity and reliability study of the Turkish version of the scale was conducted by Irmak and Erdoğan (2015).
The validity and reliability values of the original DGAS were 0.92 for Cronbach 's alpha.
The assessment is made using monoethic and polyethic diagnoses.
According to the monothetic diagnosis, a person is defined as "game addicted" if they score three (sometimes) or more on all seven items; according to the polyethic diagnosis, a person is defined as "game addicted" if they score three (sometimes) or more on at least four of the seven items.
|
6 months up to July 2024
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09.05.2023-757
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.